CDKN2A and cancer: Although some cancer cells positive in E-cadherin express p16INK4a in levels comparable to those of adjacent matrix cells negative in E-cadherin (Fig. 5b, right), the others displayed significant decreased expression of p16INK4a (Fig. 5b, left), which tended to occur in cancers of higher TNM stage (Fig. 5d).